Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis

Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis

CONCLUSIONS

In patients with severe aortic stenosis who are at increased surgical risk, TAVR with a self-expanding transcatheter aortic-valve bioprosthesis was associated with a significantly higher rate of survival at 1 year than surgical aortic-valve replacement.

(Funded by Medtronic; U.S. CoreValue High Risk Study ClinicalTrials.gov number, NCT01240902.)

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: